On May 9, 2025, Protalix BioTherapeutics, Inc. announced its financial results for the first quarter of 2025 along with a business and clinical update. This filing is part of their ongoing disclosure obligations per the Securities Exchange Act.
AI Assistant
PROTALIX BIOTHERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.